Search alternatives:
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
-
681
-
682
-
683
AMPK activators reverse the decreased expression of GR induced by DEX in cultured prefrontal cortical astrocytes.
Published 2016“…<p>(A) Representative western blot images (upper) and summarized data (lower) showing the effects of AICAR (n = 5 for each group) (A), ASP (n = 4 for each group) (B), and MET (n = 7 for each group) (C) on DEX-induced decreases of GR and pAMPK in cultured astrocytes. …”
-
684
-
685
-
686
-
687
-
688
-
689
-
690
-
691
USP-18 overexpression in RAW264.7 cells decreases production of IL-27 and IL-10.
Published 2016“…Cell supernatants were assessed using ELISA showing (A) decrease in production of mouse IL-27 in USP-18-V5 transfected cells compared to empty vector in the presence of LPS and (B) decreased levels of mouse IL-10 in USP-18-V5 transfected cells after LPS stimulation. …”
-
692
-
693
-
694
-
695
-
696
-
697
Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial
Published 2016“…After an initial increase, specific IgE against bee venom decreased in all patients completing the trial. …”
-
698
Subgroup analyses of the association between decreases in serum UA levels and poor functional outcome at 3 months.
Published 2023“…<p>The ORs and 95% CIs of poor functional outcome (defined as an mRS score of 3–6 at 3 months) are shown according to UA decrease rate grade (G1 to G4) in each subgroup. The subgroups included (<b>A</b>) age (<75 or ≥75 years), (<b>B</b>) sex (women or men), (<b>C</b>) stroke subtype (non-cardioembolic or cardioembolic), (<b>D</b>) neurological severity (NIHSS <5 or ≥5), (<b>E</b>) CKD (presence or absence), and (<b>F</b>) UA level on admission (<292 or ≥292 μmol/L for women, <351 or ≥351 μmol/L for men). …”
-
699
-
700